Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies (Q38097263)

From Wikidata

Jump to navigation Jump to search

scientific article published on 06 April 2013

Language	Label	Description	Also known as
English	Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies	scientific article published on 06 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

3 October 2022

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

0 references

primary effusion lymphoma

1 reference

3 October 2022

author name string

Arun George Paul

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Bala Chandran

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Neelam Sharma-Walia

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

publication date

6 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 August 2013

1 reference

3 October 2022

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

162

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

77-92

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Prostaglandins and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inflammation: gearing the journey to cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Infectious agents in human cancers: Lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human tumor-associated viruses and new insights into the molecular mechanisms of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The cyclooxygenases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

COX-2 and cancer: a new approach to an old problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenases in cancer: progress and perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Eicosanoids and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The stability of 13,14-dihydro-15 keto-PGE2

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Prostaglandin E receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Pro-inflammatory prostaglandins and progression of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

AH6809 antagonizes non-small cell lung cancer prostaglandin receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Targeting prostaglandin E EP receptors to inhibit metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Prostanoid receptor signaling relevant to tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA Replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

COX-2 Induction during Murine Gammaherpesvirus 68 Infection Leads to Enhancement of Viral Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The role and regulation of COX-2 during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Immunosuppression by canine distemper virus: modulation of in vitro immunoglobulin synthesis, interleukin release and prostaglandin E2 production

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Biological interactions between herpesviruses and cyclooxygenase enzymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human cytomegalovirus induced cyclooxygenase-2 in human retinal pigment epithelial cells augments viral replication through a prostaglandin pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

EBV suppresses prostaglandin E2 biosynthesis in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

NFAT and CREB Regulate Kaposi's Sarcoma-Associated Herpesvirus-Induced Cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

HHV-8-associated lymphoma: state-of-the-art review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

KSHV infection and the pathogenesis of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

HIV-associated lymphomas and gamma-herpesviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma: a computational approach through protein-protein interaction and gene regulatory networks analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma and its associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The tumor microenvironment controls primary effusion lymphoma growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Structure and function of latency-associated nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

p53 inhibition by the LANA protein of KSHV protects against cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

FLIP-mediated autophagy regulation in cell death control

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The use of nimesulide and its analogues in cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Celecoxib toxicity is cell cycle phase specific

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Rapalogs in viral cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

DNA damage checkpoints in stem cells, ageing and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Hit proteins, mitochondria and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Molecular mechanisms mediating metastasis of hypoxic breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Death pathways triggered by activated Ras in cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Common fragile sites, extremely large genes, neural development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Virus and cell RNAs expressed during Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus-specific methylation of human genes in gastric cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Transcriptional repression of TWIST1 gene by Prospero-related homeobox 1 inhibits invasiveness of hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Syndecans shed their reputation as inert molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Aquaporins--new players in cancer biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's Sarcoma Associated Herpesvirus Entry into Target Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi's sarcoma-associated herpesvirus infection in endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ( V 5, V 3, and 3 1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemopreventive response of diclofenac, a non-steroidal anti-inflammatory drug in experimental carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review).

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TP53 and mutations in human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement and infectious agents: a tale of disguise and deception

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promoter methylation of tumor-related genes in gastric carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nimesulide inhibits proliferationviainduction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why cancer and inflammation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epithelial E- and P-cadherins: role and clinical significance in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.TRSL.2013.03.004

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38097263&oldid=1742044592"